Measure | Time 0: Screening and study enrollment | Time 1: Baseline assessmenta | Time 2: 3-month follow-up | Time 3: 6-month follow-up |
---|---|---|---|---|
Timepoint (months) | 0 | 0a | 3 | 9 |
Fatigue Severity Scale | X | Â | Â | Â |
Patient Health Questionnaire – 2 | X |  |  |  |
Short Blessed Test | X | Â | Â | Â |
Demographic and disease-related information | Â | X | Xb | Xb |
Patient Determined Disease Steps Scale | Â | X | X | X |
Modified Fatigue Impact Scale | Â | X | X | X |
Multiple Sclerosis Self-Efficacy Scale | Â | X | X | X |
Perceived Deficits Questionnaire | Â | X | X | X |
Center for Epidemiologic Studies Depression Scale | Â | X | X | X |
Impact on Participation and Autonomy Questionnaire | Â | X | X | X |